Longevity Health Holdings, Inc.
XAGE
$0.61
-$0.10-14.09%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -71.88% | -84.96% | -98.65% | -99.12% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -71.88% | -84.96% | -98.65% | -99.12% | -- |
| Cost of Revenue | 149,066.67% | -- | -- | -- | -- |
| Gross Profit | 4,937.50% | -- | -- | -- | -- |
| SG&A Expenses | 54.32% | 49.12% | 48.87% | 7.34% | -1.41% |
| Depreciation & Amortization | -11.94% | -13.15% | -14.20% | -8.94% | -3.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.82% | 6.82% | -3.23% | -43.21% | -21.29% |
| Operating Income | -15.22% | 3.71% | 4.19% | 43.63% | 21.48% |
| Income Before Tax | 54.27% | 51.47% | 33.68% | 49.54% | 2.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 54.88% | 52.02% | 34.28% | 49.54% | 2.42% |
| Earnings from Discontinued Operations | -100.00% | -100.00% | -62.88% | 243.32% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.72% | 49.06% | 32.87% | 71.01% | 8.81% |
| EBIT | -15.22% | 3.71% | 4.19% | 43.63% | 21.48% |
| EBITDA | -15.74% | 3.54% | 4.01% | 44.08% | 21.75% |
| EPS Basic | 63.85% | 93.04% | 93.46% | 96.67% | 94.87% |
| Normalized Basic EPS | 62.50% | 92.60% | 92.67% | 94.57% | 94.28% |
| EPS Diluted | 63.85% | 93.04% | 93.46% | 96.67% | 94.87% |
| Normalized Diluted EPS | 62.50% | 92.60% | 92.67% | 94.57% | 94.28% |
| Average Basic Shares Outstanding | 25.75% | 39.52% | 92.69% | 283.56% | 1,538.05% |
| Average Diluted Shares Outstanding | 25.75% | 39.52% | 92.69% | 283.56% | 1,538.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |